文献速递肾移植

死亡供者肾移植延迟恢复受者的早期激素撤减

Early Steroid Withdrawal in Deceased-Donor Kidney Transplant Recipients with Delayed Graft Function.
PubMed 文献 · J Am Soc Nephrol · 2019-12-18

该研究基于美国移植受者科学登记系统,分析2005至2017年间110,019例成人死亡供者肾移植受者,评估延迟移植物功能(DGF)与早期激素撤减(ESW)使用的关联。结果显示DGF受者接受ESW的几率较低(aOR=0.67),且ESW在DGF受者中与移植物失败风险增加相关(aHR=1.16),对死亡率无改善。

要点

  • DGF受者接受ESW的几率显著低于即刻功能受者(aOR=0.67)。
  • DGF受者中,ESW与移植物失败风险增加相关(aHR=1.16)。
  • DGF受者中,ESW对死亡率无改善(aHR=1.00)。

核心结论

  • 美国肾移植中心对DGF受者使用ESW存在不一致性。
  • ESW可能导致DGF受者移植结局更差。

研究设计与样本

  • 基于美国移植受者科学登记系统的回顾性队列研究,纳入2005至2017年间110,019例成人死亡供者肾移植受者。
  • 使用多变量logistic和Cox回归,并纳入DGF与ESW交互项。

主要发现

  • 总体29.2%的肾移植受者接受了ESW。
  • DGF受者接受ESW的校正比值比为0.67(原文aOR=0.600.670.75)。
  • 261个移植中心中,31个中心(11.9%)的校正比值比<0.5,22个中心(8.4%)>1.0。
  • IGF受者中,ESW与急性排斥反应风险增加相关(aOR=1.16),移植物失败风险略增(aHR=1.06),但死亡率降低(aHR=0.89)。
  • DGF受者中,ESW与急性排斥反应风险增加相关(aOR=1.12,95% CI 1.02-1.23),移植物失败风险更明显增加(aHR=1.16,95% CI 1.08-1.26),死亡率无改善(aHR=1.00,95% CI 0.94-1.07)。

临床怎么用

  • 对于死亡供者肾移植后发生DGF的受者,应谨慎考虑早期激素撤减策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Early steroid withdrawal (ESW) is associated with acceptable outcomes in kidney transplant (KT) recipients. Recipients with delayed graft function (DGF), however, often have a suboptimal allograft milieu, which may alter the risk/benefit equation for ESW. This may contribute to varying practices across transplant centers. METHODS: Using the Scientific Registry of Transplant Recipients, we studied 110,019 adult deceased-donor KT recipients between 2005 and 2017. We characterized the association of DGF with the use of ESW versus continued steroid maintenance across KT centers, and quantified the association of ESW with acute rejection, graft failure, and mortality using multivariable logistic and Cox regression with DGF-ESW interaction terms. RESULTS: Overall 29.2% of KT recipients underwent ESW. Recipients with DGF had lower odds of ESW (aOR=0.600.670.75). The strength of this association varied across 261 KT centers, with center-specific aOR of <0.5 at 31 (11.9%) and >1.0 at 22 (8.4%) centers. ESW was associated with benefits and harms among recipients with immediate graft function (IGF), but only with harms among recipients with DGF. ESW was associated with increased acute rejection (aOR=1.091.161.23), slightly increased graft failure (aHR=1.011.061.12), but decreased mortality (aHR=0.860.890.93) among recipients with IGF. Among recipients with DGF, ESW was associated with a similar increase in rejection (aOR=1.12; 95% CI, 1.02 to 1.23), a more pronounced increase in graft failure (aHR=1.16; 95% CI, 1.08 to 1.26), and no improvement in mortality (aHR=1.00; 95% CI, 0.94 to 1.07). DGF-ESW interaction was statistically significant for graft failure (P=0.04) and mortality (P=0.003), but not for rejection (P=0.6). CONCLUSIONS: KT centers in the United States use ESW inconsistently in recipients with DGF. Our findings suggest ESW may lead to worse KT outcomes in recipients with DGF.

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Bae S, Garonzik Wang JM, Massie AB, et al. Early Steroid Withdrawal in Deceased-Donor Kidney Transplant Recipients with Delayed Graft Function. J Am Soc Nephrol. 2019. PMID: 31852720. doi:10.1681/ASN.2019040416

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。